ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Phase I Dose-Escalation Study of SR271425, an Intravenously Dosed Thioxanthone Analog, Administered Weekly in Patients With Refractory Solid Tumors
American Journal of Clinical Oncology
◽
10.1097/coc.0b013e318178331b
◽
2009
◽
Vol 32
(1)
◽
pp. 9-14
◽
Cited By ~ 5
Author(s):
A Craig Lockhart
◽
Emiliano Calvo
◽
Anthony W. Tolcher
◽
Eric K. Rowinsky
◽
Gareth Shackleton
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Dose Escalation Study
Download Full-text
Related Documents
Cited By
References
Phase I Dose‐Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid Tumors
The Oncologist
◽
10.1634/theoncologist.2016-0257
◽
2017
◽
Vol 22
(4)
◽
pp. 377
◽
Cited By ~ 8
Author(s):
Jennifer Wheler
◽
David Mutch
◽
Joanne Lager
◽
Christelle Castell
◽
Li Liu
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Dose Escalation Study
Download Full-text
A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-18-2014
◽
2018
◽
Vol 25
(2)
◽
pp. 496-505
◽
Cited By ~ 13
Author(s):
Florence Atrafi
◽
Harry J.M. Groen
◽
Lauren A. Byers
◽
Elena Garralda
◽
Martijn P. Lolkema
◽
...
Keyword(s):
Lung Cancer
◽
Phase I
◽
Small Cell Lung Cancer
◽
Solid Tumors
◽
Cell Lung Cancer
◽
Dose Escalation
◽
Small Cell
◽
Small Cell Lung
◽
Dose Escalation Study
◽
Extensive Stage
Download Full-text
A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors
Investigational New Drugs
◽
10.1007/s10637-017-0467-7
◽
2017
◽
Vol 36
(1)
◽
pp. 36-44
◽
Cited By ~ 2
Author(s):
Janice M. Mehnert
◽
Gerald Edelman
◽
Mark Stein
◽
Heather Camisa
◽
Joanne Lager
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Kinase Inhibitor
◽
Tablet Formulation
◽
Dose Escalation Study
◽
Phosphoinositide 3 Kinase
Download Full-text
A Phase I Dose–Escalation Study of Regorafenib (BAY 73–4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-11-1900
◽
2012
◽
Vol 18
(9)
◽
pp. 2658-2667
◽
Cited By ~ 208
Author(s):
Klaus Mross
◽
Annette Frost
◽
Simone Steinbild
◽
Susanne Hedbom
◽
Martin Büchert
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-009-1209-0
◽
2009
◽
Vol 66
(4)
◽
pp. 669-680
◽
Cited By ~ 32
Author(s):
Francisco Robert
◽
Alan Sandler
◽
Joan H. Schiller
◽
Glenn Liu
◽
Karen Harper
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-014-2567-9
◽
2014
◽
Vol 74
(5)
◽
pp. 917-925
◽
Cited By ~ 9
Author(s):
Carlos R. Becerra
◽
Paul Conkling
◽
Nicholas Vogelzang
◽
Hilary Wu
◽
Shengyan Hong
◽
...
Keyword(s):
Monoclonal Antibody
◽
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
Phase I Dose-Escalation Study of MEDI-573, a Bispecific, Antiligand Monoclonal Antibody against IGFI and IGFII, in Patients with Advanced Solid Tumors
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-14-0114
◽
2014
◽
Vol 20
(18)
◽
pp. 4747-4757
◽
Cited By ~ 30
Author(s):
Paul Haluska
◽
Michael Menefee
◽
Elizabeth R. Plimack
◽
Jonathan Rosenberg
◽
Donald Northfelt
◽
...
Keyword(s):
Monoclonal Antibody
◽
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
Abstract B27: A phase I dose escalation study of the MDM2 inhibitor DS-3032b in patients with advanced solid tumors and lymphomas
10.1158/1535-7163.targ-15-b27
◽
2015
◽
Cited By ~ 1
Author(s):
Todd Bauer
◽
David Hong
◽
Neeta Somaiah
◽
Charles Cai
◽
Saeheum Song
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
◽
Mdm2 Inhibitor
Download Full-text
Abstract LB-410: Phase I dose escalation study of MM-121, a fully human monoclonal antibody to ErbB3, in patients with advanced solid tumors
10.1158/1538-7445.am2011-lb-410
◽
2011
◽
Cited By ~ 3
Author(s):
Crystal S. Denlinger
◽
Vicki L. Keedy
◽
James M. Cleary
◽
William Kubasek
◽
Matthew Onsum
◽
...
Keyword(s):
Monoclonal Antibody
◽
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Human Monoclonal Antibody
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
Abstract 1752: A phase I/IIa, first time in human, open-label dose-escalation study of GSK2636771 in subjects with advanced solid tumors with PTEN deficiency
10.1158/1538-7445.am2012-1752
◽
2012
◽
Cited By ~ 4
Author(s):
Samuel C. Blackman
◽
Shelby D. Gainer
◽
Benjamin B. Suttle
◽
Konstantine W. Skordos
◽
Joel D. Greshock
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Open Label
◽
Dose Escalation Study
◽
Label Dose
◽
First Time
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close